GLAUKOS Corp GKOS
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2015-06-25
GLAUKOS Corp financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $507.4M | $383.5M | $314.7M | $282.9M | $294.0M |
| Gross profit | $282.8M | $289.5M | $239.1M | $213.9M | $227.4M |
| SG&A expense | $331.7M | $261.2M | $224.1M | $192.9M | $179.3M |
| Operating income | -$199.6M | -$122.4M | -$128.7M | -$82.3M | -$32.9M |
| Interest expense | — | — | $13.6M | $13.7M | $13.4M |
| Income tax | -$5.4M | $771,000 | $934,000 | $766,000 | $326,000 |
| Net income | -$187.7M | -$146.4M | -$134.7M | -$99.2M | -$49.6M |
| EPS (diluted) | $-3.28 | $-2.77 | $-2.78 | $-2.09 | $-1.07 |
| Operating cash flow | -$14.8M | -$61.3M | -$57.8M | -$33.1M | $24.7M |
| Free cash flow | -$22.5M | -$67.6M | -$78.0M | -$63.3M | -$23.1M |
| Cash & equivalents | $90.8M | $169.6M | $93.5M | $119.5M | $100.7M |
| Inventory | $63.6M | $57.7M | $42.0M | $37.8M | $23.0M |
| Total assets | $893.5M | $974.8M | $940.4M | $1.0B | $1.0B |
| Total liabilities | $237.3M | $207.8M | $478.6M | $472.4M | $462.5M |
| Shareholders' equity | $656.2M | $766.9M | $461.8M | $530.0M | $587.2M |
Source: SEC EDGAR filings · CIK 0001192448 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.